Johnson & Johnson MedTech has introduced the KINCISE 2 Surgical Automated System, intended for use in knee and hip revision procedures, enhancing surgical efficiency.
This tool aims to minimise the physical strain on surgeons during the procedures.
It is designed to offer control and alleviate the load associated with manual impaction in primary and revision hip surgeries, as well as revision knee replacement surgeries.
The company noted that surgeons in the field of orthopaedics are increasingly confronted with complex challenges in the operating room such as longer procedures, the physical demands of surgery, and higher case volumes.
KINCISE 2 aims to address the issues of monotonous, high-force tasks, including repeated mallet strikes, which have been associated with overuse injuries, with the majority of surgeons reporting musculoskeletal pain, especially in their hands, neck, and lower back.
Building on the company鈥檚 first-generation KINCISE System, the new system features design elements such as increased reverse energy to aid in broach removal and push-to-lock adaptors to facilitate secure connections.
US Tariffs are shifting - will you react or anticipate?
Don鈥檛 let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAccording to the company, the Acetabular Cup Extraction addition positions the system as the first and only automated surgical impactor approved for the removal of well-fixed acetabular components, thereby widening its utility in complex hip revisions.
Currently available for commercial use in the US, the system is equipped with a compact design and several grip options.
Johnson & Johnson聽MedTech Orthopaedics company group chair Aldo Denti said: 鈥淭he KINCISE 2 System exemplifies the needs-based innovation we鈥檙e bringing to orthopaedics this year.
鈥淎s more patients undergo joint replacements earlier in life, the demand for revision surgeries is rising. The KINCISE System has demonstrated the ability to help surgeons manage those complex cases by reducing operating time聽and providing procedural control聽– ultimately supporting better outcomes for patients.鈥�
Last month, the company launched the Soundstar Crystal ultrasound catheter in the US, which is intended for use in intracardiac echocardiography imaging during cardiac ablation procedures.
